M. Ristig

Safety and Tolerability of Sequential Pegylated IFN-α2a and Tenofovir for Hepatitis B Infection in HIV+ Individuals

O. Cummings, J. Aberg, E. Overton, 2007, HIV clinical trials.

Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed.

P. Tebas, W. Powderly, J. Aberg, 2002, The Journal of infectious diseases.

Cure of acute hepatitis C in HIV co-infection?

P. Tebas, J. Aberg, R. Qaqish, 2004, Journal of clinical gastroenterology.

Management of chronic hepatitis B in an HIV-positive patient with 3TC-resistant hepatitis B virus.

P. Tebas, M. Lisker‐Melman, J. Crippin, 2003, AIDS patient care and STDs.

Hepatic steatosis and HIV infection.

W. Powderly, H. Drechsler, M. Ristig, 2005, AIDS patient care and STDs.

Increasing prevalence of resistance mutations in antiretroviral-naïve individuals with established HIV-1 infection from 1996-2002 in St. Louis

P. Tebas, W. Powderly, M. Arens, 2002, HIV clinical trials.

Nonnucleoside Reverse Transcriptase Inhibitor Resistance Among Antiretroviral-Naive HIV-Positive Pregnant Women

P. Tebas, J. Aberg, C. Williamson, 2003, Journal of acquired immune deficiency syndromes.